SS Innovations Int'l Achieves First Pediatric Telesurgery

By Ahmed Jameison • Wednesday, September 17 06:03 • Permanent Link

SS Innovations International, Inc. (NASDAQ: SSII) has achieved a major milestone with the successful completion of the world's first pediatric pyeloplasty telesurgery using the company's SSI Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, managing director of Preeti Urology & Kidney Hospitals, performed the robotic procedure remotely from SS Innovations' headquarters in Gurugram, India, nearly 1,000 miles away from the 16-month-old patient at Preeti Hospital in Hyderabad, India.

This groundbreaking achievement highlights the strengths of the SSI Mantra in robotic telesurgery and signifies a significant opportunity in the pediatric surgical space. Dr. Sudhir Srivastava, chairman of the board and chief executive officer of SS Innovations, emphasized the potential benefits of robotic surgery in terms of precision, invasiveness, recovery times, and outreach to patients in rural and remote areas.

Notably, more than 50 telesurgeries have been performed using the SSI Mantra surgical robotic system, spanning various categories including pediatric, cardiac, urology, gynecology, oncology, and general surgery. SS Innovations aims to address the unmet surgical robotic needs in the pediatric market and plans to expand the capabilities of the SSI Mantra in pediatric robotic surgery through the development of smaller instrumentation.

As of the most recent announcement, SS Innovations continues to develop innovative surgical robotic technologies with the vision of making robotic surgery more affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSI Mantra surgical robotic system and its comprehensive suite of SSI Mudra surgical instruments, which support a variety of surgical procedures, including robotic cardiac surgery. SS Innovations, an American company headquartered in India, is committed to expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Following these announcements, the company's shares moved 3.7%, and are now trading at a price of $5.60. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.